Correlation Between Deciphera Pharmaceuticals and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Neurocrine Biosciences, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Neurocrine Biosciences.

Diversification Opportunities for Deciphera Pharmaceuticals and Neurocrine Biosciences

0.0

Correlation Coefficient

Deciphera Pharmaceuticals  Neurocrine Biosciences

Pay attention - limited upside

The 3 months correlation between Deciphera and Neurocrine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between Deciphera Pharmaceuticals and Neurocrine Biosciences

If you would invest  10,975  in Neurocrine Biosciences on May 5, 2025 and sell it today you would earn a total of  1,916  from holding Neurocrine Biosciences or generate 17.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Deciphera Pharmaceuticals LLC  vs.  Neurocrine Biosciences

Deciphera Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Deciphera Pharmaceuticals LLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Deciphera Pharmaceuticals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Neurocrine Biosciences

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Deciphera Pharmaceuticals and Neurocrine Biosciences

The main advantage of trading using opposite Deciphera Pharmaceuticals and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind Deciphera Pharmaceuticals LLC and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.